Yunnan Baiyao
云南白药
Established in 1902, Yunnan Baiyao Group is a leading enterprise in the domestic health industry. The company’s products primarily include the Yunnan Baiyao series and natural medicine series. Its business covers pharmaceuticals, health products, traditional Chinese medicine resources, and pharmaceutical logistics.
Yunnan Baiyao was founded in 1971, listed on the Shenzhen Stock Exchange as a Yunnan-based company in 1993, unified its brand in 1996, successfully implemented corporate reengineering in 1999, launched the “Stabilize the Center, Expand the Wings” product strategy in 2005, and began implementing the “New Yunnan Baiyao, Big Health” industrial strategy in 2010. It has gradually developed from a traditional Chinese medicine company into one of China’s leading enterprises in the health industry.
In 2016, Yunnan Baiyao implemented mixed ownership reform through capital increase and share expansion at the controlling level, absorbing over 20 billion RMB in private capital from Xinhuadu and Jiangsu Yuyue. In April 2019, approved by the China Securities Regulatory Commission, Yunnan Baiyao Group absorbed and merged Yunnan Baiyao Holdings Co., Ltd., achieving overall listing. State-owned and private capital coexist as the two major shareholders, streamlining the system and activating the mechanism. Yunnan Baiyao’s mixed reform, because of its thoroughness and innovation, is hailed as the “Yunnan Baiyao Model” of mixed reform.
Yunnan Baiyao Group’s main business is clear and well-operated, mainly divided into four sectors: pharmaceuticals, health products, traditional Chinese medicine resources, and pharmaceutical logistics. These sectors work both independently and support each other, forming a complete value chain from selection, cultivation, research, manufacturing to health products and services. The company has formed an integrated market value system and an economic ecosystem with the integration of primary, secondary, and tertiary industries.
In 2008, the company established the strategy of developing multiple brands under the Yunnan Baiyao flagship brand, and it has now formed a system of multiple sub-brands under the parent brand. With Yunnan Baiyao as the foundation, the company has extended to create various drug brands such as Yunfeng, Tongqiaoqiao, and Yunjian; personal health care product brands like Rizi, Jinkoujian, Langjian, Yangyuanqing, and Caizhiji; and native medicinal and big health product brands like Baiyao Yangsheng, Baoqi, Qiancaotang, Qiangaomeizi, and Tianzi Hong.
The products are sold well in China, Southeast Asia, and have gradually entered developed countries such as Europe, America, and Japan, with hundreds of millions of people having used the company’s products. In terms of pharmaceuticals, Yunnan Baiyao’s adhesive bandages, aerosol sprays, and medicated powders continue to lead in terms of sales in the Chinese market. In the health product sector, Yunnan Baiyao toothpaste ranked among the top in national sales in 2018. In the field of traditional Chinese medicine resources, the representative product of high-quality Sanqi (Panax notoginseng) within Yunnan province is Baoqi Sanqi, represented by freeze-drying and ultrafine powder technologies.
In the future, Yunnan Baiyao will globally allocate resources to respond to the Chinese market, adhere to the development strategy of both internal and external growth, focus on networking, platformization, and the ecosystem, strengthen competitive strength, continuously create value for users and investors, build a sustainable century-old foundation, and strive to become a national team representing China’s participation in global competition in the big health industry, and create another century of brilliance.
Best-selling Products from the Yunnan Baiyao Brand：
